stage ii multiple myeloma
Showing 1 - 25 of 48
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,
Active, not recruiting
- Stage I Multiple Myeloma
- +2 more
- dexamethasone
- +4 more
-
Chicago, Illinois
- +4 more
Sep 3, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,
Completed
- Refractory Multiple Myeloma
- +4 more
- total marrow irradiation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 25, 2021
Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Bronx, Manhasset, New York (aflibercept)
Terminated
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma
- aflibercept
-
Bronx, New York
- +5 more
Jan 29, 2021
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in
Completed
- Acute Undifferentiated Leukemia
- +63 more
- total-body irradiation
- +7 more
-
Seattle, Washington
- +1 more
Jan 17, 2020
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic
Completed
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
- +76 more
- fludarabine phosphate
- +6 more
-
Tucson, Arizona
- +10 more
Jan 17, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- chemotherapy
- +6 more
-
Duarte, California
- +4 more
Dec 24, 2019
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Philadelphia (Bendamustine HCl,
Completed
- Stage I Multiple Myeloma
- +2 more
- Bendamustine hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 27, 2019
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin
Completed
- Refractory Multiple Myeloma
- +3 more
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
May 2, 2019
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in New York (romiplostim)
Terminated
- Refractory Multiple Myeloma
- +4 more
- romiplostim
-
New York, New YorkNYU Cancer Institute
Sep 13, 2018
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in United States (drug, other, procedure)
Completed
- Stage I Multiple Myeloma
- +2 more
- bortezomib
- +5 more
-
Scottsdale, Arizona
- +3 more
Aug 13, 2018
Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Scottsdale, Rochester, Charleston (carfilzomib,
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Los Angeles (dalteparin, lenalidomide,
Terminated
- Stage I Multiple Myeloma
- +2 more
- dalteparin
- +3 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Nov 27, 2017
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (cyclophosphamide, pegylated
Terminated
- Refractory Multiple Myeloma
- +3 more
- cyclophosphamide
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 7, 2017
Multiple Myeloma in Relapse, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Pittsburgh, Madison (bevacizumab,
Completed
- Multiple Myeloma in Relapse
- +2 more
- bevacizumab
- +2 more
-
Pittsburgh, Pennsylvania
- +1 more
Aug 2, 2017
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (drug, biological, procedure)
Completed
- Refractory Multiple Myeloma
- +3 more
- melphalan
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 16, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +82 more
- plerixafor
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 26, 2017
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Columbus (cryotherapy, questionnaire
Completed
- Refractory Multiple Myeloma
- +3 more
- cryotherapy
- +2 more
-
Columbus, OhioOhio State University Medical Center
Jun 23, 2017
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (clarithromycin, thalidomide,
Completed
- Refractory Multiple Myeloma
- +3 more
- clarithromycin
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 22, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +178 more
- fludarabine phosphate
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (lenalidomide)
Completed
- Refractory Multiple Myeloma
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 19, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +96 more
- cyclophosphamide
- +10 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 10, 2017
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Detroit (other, drug, biological,
Terminated
- Refractory Multiple Myeloma
- +3 more
- pharmacological study
- +8 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 8, 2017